Induction of remission of idiopathic anaphylaxis with rituximab

J Allergy Clin Immunol. 2014 Oct;134(4):981-3. doi: 10.1016/j.jaci.2014.05.032. Epub 2014 Jul 10.

Authors

Arturo Borzutzky¹, Pamela S Morales², Verónica Mezzano³, Sofía Nussbaum², A Wesley Burks⁴

Affiliations

¹ Immunology, Allergy and Rheumatology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: arturobor@med.puc.cl.
² Immunology, Allergy and Rheumatology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
³ Department of Rheumatology and Clinical Immunology at the School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
⁴ Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.

PMID: 25018095
DOI: 10.1016/j.jaci.2014.05.032

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Allergens / adverse effects
Allergens / immunology
Anaphylaxis / diagnosis
Anaphylaxis / drug therapy*
Anaphylaxis / immunology
Antibodies, Monoclonal, Murine-Derived / administration & dosage*
Antibodies, Monoclonal, Murine-Derived / adverse effects
Asthma / diagnosis
Asthma / drug therapy*
Asthma / immunology
B-Lymphocytes / drug effects*
B-Lymphocytes / immunology
Drug Resistance
Epinephrine / administration & dosage
Female
Food / adverse effects
Humans
Immunoglobulin E / blood
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Immunotherapy* / methods
Lymphocyte Depletion
Recurrence
Remission Induction
Rhinitis, Allergic / diagnosis
Rhinitis, Allergic / drug therapy*
Rhinitis, Allergic / immunology
Rituximab

Substances

Allergens
Antibodies, Monoclonal, Murine-Derived
Immunosuppressive Agents
Immunoglobulin E
Rituximab
Epinephrine